Here begins the text.

Patient Centricity WG

About this WG

This WG looks into topics related to patient engagement into drug and medical device regulations in order to enhance the incorporation of the patient’s voice in activities of PMDA.


May, 2019


Office of Planning and Operations
Office of International Programs
Office of New Drug I-V
Office of Cellular and Tissue-based Products
Office of Vaccines and Blood Products
Office of Medical Devices I-II
Office of Informatics and Management for Safety
Office of Pharmacovigilance I-II
Office of Medical Informatics and Epidemiology
Office of Review Management
Office of Research Promotion


Pharmaceuticals and Medical Devices Agency Guidance on Patient Participation (September 7, 2021)

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

Patient Centricity WG